(XNAS) Xtrackers NASDAQ 100 1C - Ratings and Ratios
ETF, Shares, Equity, Growth, Large-Cap, US, Market
Description: XNAS Xtrackers NASDAQ 100 1C
The Xtrackers NASDAQ100 UCITS ETF1C CHF is a Swiss-based ETF that tracks the Morningstar US LM Brd Growth NR USD Index, providing investors with exposure to US large-cap growth equities. This ETF is designed to replicate the performance of the underlying index, which comprises a diverse range of growth-oriented stocks.
From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with the short-term Simple Moving Average (SMA20) at 40.87, slightly above the current price of 40.71. The medium-term SMA50 at 38.52 suggests a bullish crossover has occurred, indicating potential for further upside. The long-term SMA200 at 41.00 is also a key level to watch, as a break above this could signal a resumption of the uptrend. The Average True Range (ATR) of 0.63, or 1.54%, indicates moderate volatility, and the 52-week high and low of 46.11 and 33.20, respectively, provide context for the ETFs recent price movements.
Fundamentally, the ETFs Assets Under Management (AUM) stand at 1166.57M CHF, indicating a sizable presence in the market. As the ETF tracks the NASDAQ-100 Index, it provides exposure to the largest and most liquid technology and growth stocks in the US market, such as Apple, Microsoft, and Alphabet.
Forecasting future performance using a combination of technical and fundamental data, we can anticipate that the ETF will continue to track the underlying index. Given the current technical setup, with the SMA20 and SMA50 in a bullish configuration, and the AUM indicating a stable investor base, we can expect the ETFs price to potentially move towards the 52-week high of 46.11 in the near term, assuming the underlying index continues to perform well. However, a break below the SMA50 at 38.52 could signal a reversal in this trend. Investors should closely monitor the ETFs price action relative to the SMA200 and the ATR to gauge potential future movements.
Additional Sources for XNAS ETF
XNAS ETF Overview
Market Cap in USD | 1,474m |
Category | US Large-Cap Growth Equity |
TER | 0.20% |
IPO / Inception | 2021-01-21 |
XNAS ETF Ratings
Growth Rating | 40.4 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -11.5 |
Analysts | - |
Fair Price Momentum | 37.23 CHF |
Fair Price DCF | - |
XNAS Dividends
Currently no dividends paidXNAS Growth Ratios
Growth Correlation 3m | 83% |
Growth Correlation 12m | 15.7% |
Growth Correlation 5y | 79.6% |
CAGR 5y | 13.83% |
CAGR/Max DD 5y | 0.39 |
Sharpe Ratio 12m | 0.58 |
Alpha | -13.81 |
Beta | 0.996 |
Volatility | 19.54% |
Current Volume | 0.7k |
Average Volume 20d | 2.3k |
As of July 03, 2025, the stock is trading at CHF 41.33 with a total of 715 shares traded.
Over the past week, the price has changed by -0.64%, over one month by +2.84%, over three months by +3.82% and over the past year by +0.66%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers NASDAQ 100 1C (SW:XNAS) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.38 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XNAS is around 37.23 CHF . This means that XNAS is currently overvalued and has a potential downside of -9.92%.
Xtrackers NASDAQ 100 1C has no consensus analysts rating.
According to our own proprietary Forecast Model, XNAS Xtrackers NASDAQ 100 1C will be worth about 43.6 in July 2026. The stock is currently trading at 41.33. This means that the stock has a potential upside of +5.56%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 43.6 | 5.6% |